Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Korean J Anesthesiol ; 73(5): 425-433, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32987492

RESUMEN

BACKGROUND: Regional nerve blocks are an integral part of multimodal analgesia and should be chosen based on their efficacy, convenience, and minimal side effects. Here, we compare the use of pectoral (PEC II) and serratus-intercostal fascial plane (SIFP) blocks in breast carcinoma cases undergoing modified radical mastectomy (MRM) in terms of the postoperative analgesic efficacy and shoulder mobility. METHODS: The primary outcome of this prospective controlled study was to compare the postoperative static and dynamic pain scores, and the secondary outcome was to assess the shoulder pain, range of shoulder joint motion, and hemodynamic parameters. Sixty patients were randomly allocated to three groups and given general anesthesia. All patients received paracetamol, diclofenac, and rescue doses of tramadol based on the Institute's Acute Pain Service (APS) policy. No block was performed in group C (control), whereas groups P and S received PEC II and SIFP blocks, respectively, before surgical incision. RESULTS: The groups were comparable in terms of age, weight, height, and body mass index distribution (P > 0.05). Dynamic pain relief was significantly better 12 and 24 h postoperatively in groups P (P = 0.034 and P = 0.04, respectively) and S (P = 0.01 and P = 0.02, respectively) compared to group C. Shoulder pain relief and shoulder mobility were better in group S, while the hemodynamic parameters were more stable in group P. CONCLUSIONS: Both SIFP and PEC blocks have comparable dynamic and static pain relief with better shoulder pain scores in patients receiving SIFP.


Asunto(s)
Neoplasias de la Mama/cirugía , Mastectomía Radical Modificada/efectos adversos , Bloqueo Nervioso/métodos , Dimensión del Dolor/métodos , Dolor Postoperatorio/prevención & control , Adulto , Neoplasias de la Mama/diagnóstico , Método Doble Ciego , Fascia/efectos de los fármacos , Fascia/inervación , Femenino , Humanos , Músculos Intercostales/efectos de los fármacos , Músculos Intercostales/inervación , Músculos Intermedios de la Espalda/efectos de los fármacos , Músculos Intermedios de la Espalda/inervación , Mastectomía Radical Modificada/tendencias , Persona de Mediana Edad , Bloqueo Nervioso/tendencias , Dimensión del Dolor/tendencias , Dolor Postoperatorio/diagnóstico , Dolor Postoperatorio/etiología , Músculos Pectorales/efectos de los fármacos , Músculos Pectorales/inervación , Estudios Prospectivos
2.
Indian J Anaesth ; 64(Suppl 4): S220-S226, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33311723

RESUMEN

BACKGROUND: Optimal intra-operative fluid therapy in renal transplantation (RT) is essential to ensure adequate graft function while preventing fluid overload related complications. This RCT was to compare the intraoperative goal directed fluid therapy (GDFT) based either on corrected flow time (CFT), measured by trans oesophageal Doppler (TED) or on the stroke volume variation (SVV), by FloTrac in patients undergoing living donor RT. METHODS: This prospective, randomised controlled trial (RCT) was done on 60 end stage renal disease (ESRD) patients, American Society of Anaesthesiologists(ASA) grade III-IV, age 18 to 65 years of either sex, scheduled for living donor RT under general anaesthesia. They were randomly divided into two groups: TED group (n = 30) and FloTrac™ group (n = 30) and administered GDFT, based upon CFT (TED) and SVV (FloTrac™). The primary outcome was to compare the total fluid and number of fluid boluses administered intraoperatively, while the secondary outcomes were to compare any postoperative complications due to fluid overload and allograft function, assessed by serial serum creatinine levels up to 90 days postoperatively. RESULTS: The mean total intra-operative fluid [3991.67 ± 856.32 vs. 3543.33 ± 1131.35, P = 0.089] and the amount of fluid administered per kg body weight per hour [13.32 ± 4.67 vs. 11.82 ± 4.76, P = 0.222] were lesser in the FloTrac compared to TED group, though not statistically significant. However, the postoperative incidence of allograft dysfunction, including rejection (P = 0.743) and acute tubular necrosis (ATN) (P = 0.999), and other complications (P = 0.643) were comparable. CONCLUSIONS: Both TED and FloTrac devices can be used effectively to guide GDFT in RT, However, lesser total fluid was required in the FloTrac group, which may lead to a lesser number of fluid-related postoperative complications.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA